Phosphatidylethanolamine plasmalogen enhances the inhibiting effect of phosphatidylethanolamine on γ-secretase activity

Journal of Biochemistry

Volumn 157, Issue 5, 2015, Pages 301-309

  Onodera, Tomoko ^a   Futai, Eugene ^a   Kan, Eiichiro ^a   Abe, Naoki ^a   Uchida, Takafumi ^a   Kamio, Yoshiyuki ^b   Kaneko, Jun ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b SHOKEI GAKUIN UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; amyloid beta; phosphatidylethanolamine plasmalogen; yeast microsomes; secretase activity

Indexed keywords

GAMMA SECRETASE; MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE PLASMALOGEN; PLASMALOGEN; UNCLASSIFIED DRUG; PHOSPHATIDAL ETHANOLAMINES; PROTEOLIPID; PROTEOLIPOSOMES; SECRETASE;

ARTICLE; BACTERIAL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; INNER MEMBRANE; LIMIT OF DETECTION; MICROSOME; MICROSOME MEMBRANE; NONHUMAN; PHOSPHOLIPID MEMBRANE; SELENOMONAS RUMINANTIUM; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; HUMANS; PHOSPHATIDYLETHANOLAMINES; PLASMALOGENS; PROTEOLIPIDS;

EID: 84941077798     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvu074     Document Type: Article

References (43)

1. Nagan, N. and Zoeller, R.A. (2001) Plasmalogens: biosynthesis and functions. Prog. Lipid Res. 40, 199-229
2. Farooqui, A.A. and Horrocks, L.A. (2001) Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 7, 232-245
3. Horrocks, L.A. and Sharma, M. (1982) Plasmalogens and O-alkyl glycerophospholipids in Phospholipids in New Comprehensive Biochemistry (Hawthorne, J.N. and Ansell, G.B., eds.) Vol. 4 pp. 51-93, Elsevier Biomedical Press, Amsterdam
4. Han, X., Holtzman, D.M., and McKeel, D.W. Jr (2001) Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77, 1168-1180
5. Wegner, G.H. and Foster, E.M. (1963) Incorporation of isobutyrate and valerate into cellular plasmalogen by Bacteroides succinogenes. J. Bacteriol. 85, 53-61
6. Goldfine, H. (1964) Composition of the aldehydes of Clostridium butyricum plasmalogens. Cyclopropane aldehydes. J. Biol. Chem. 239, 2130-2134
7. Kamio, Y., Kanegasaki, S., and Takahashi, H. (1969) Occurrence of plasmalogens in anaerobic bacteria. J. Gen. Appl. Microbiol. 15, 439-451
8. Ginsberg, L., Rafique, S., Xuereb, J.H., Rapoport, S.I., and Gershfeld, N.L. (1995) Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res. 698, 223-226
9. Sisodia, S.S. and St George-Hyslop, P.H. (2002) gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3, 281-290
10. Bartzokis, G. (2004) Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging 25, 5-18
11. Bartzokis, G., Lu, P.H., and Mintz, J. (2007) Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement. 3, 122-125
12. Bartzokis, G. (2011) Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 32, 1341-1371
13. Yagishita, S., Futai, E., and Ishiura, S. (2008) In vitro reconstitution of gamma-secretase activity using yeast microsomes. Biochem. Biophys. Res. Commun. 377, 141-145
14. Futai, E., Yagishita, S., and Ishiura, S. (2009) Nicastrin is dispensable for gamma-secretase protease activity in the presence of specific presenilin mutations. J. Biol. Chem. 284, 13013-13022
15. Yonemura, Y., Futai, E., Yagishita, S., Suo, S., Tomita, T., Iwatsubo, T., and Ishiura, S. (2011) Comparison of presenilin 1 and presenilin 2 g-secretase activities using a yeast reconstitution system. J. Biol. Chem. 286, 44569-44575
16. Edbauer, D., Winkler, E., Regula, J.T., Pesold, B., Steiner, H., and Haass, C. (2003) Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486-488
17. Kamio, Y. and Takahashi, H. (1980) Isolation and characterization of outermembranes of Selenomonas ruminantium: lipid compositions. J. Bacteriol. 141, 888-898
18. Kamio, Y., Kanegasaki, S., and Takahashi, H. (1970) Fatty acid and aldehyde compositions in phospholipids of Selenomonas ruminantium with reference to growth conditions. J. Gen. Appl. Microbiol. 16, 29-37
19. Fiske, C.H. and Subbarow, Y. (1925) The colorimetric determination of phosphorus. J. Biol. Chem. 66, 375-400
20. Selkoe, D.J. (2011) Alzheimer's disease. Cold Spring Harb. Perspect. Biol. 3, pii: a004457
21. Wolfe, M.S. (2006) The gamma-secretase complex: membrane-embedded proteolytic ensemble. Biochemistry 45, 7931-7939
22. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C.G., and Simons, K. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. U S A. 95, 6460-6464
23. Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lutjohann, D., Keller, P., Runz, H., Kuhl, S., Bertsch, T., von Bergmann, K., Hennerici, M., Beyreuther, K., and Hartmann, T. (2001) Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Ab42 and Ab40 in vitro and in vivo. Proc. Natl Acad. Sci. U S A. 98, 5856-5861
24. Di Paolo, G. and Kim, T.W. (2011) Linking lipids to Alzheimers disease: cholesterol and beyond. Nat. Rev. Neurosci. 12, 284-296
25. Grimm, M.O., Grimm, H.S., Pätzold1, A.J., Zinser, E.G., Halonen, R., Duering, M., Tschäpe, J.A., De Strooper, B., Müller, U., Shen, J., and Hartmann, T. (2005) Regulation of cholesterol and sphingomyelin metabolism by amyloid-b and presenilin. Nat. Cell. Biol. 7, 1118-1123
26. Stokes, C.E. and Hawthorne, J.N. (1987) Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. J. Neurochem. 48, 1018-1021
27. Grimm, M.O., Kuchenbecker, J., Rothhaar, T.L., Grösgen, S., Hundsdoefer, B., Berg, V.K., Friss, P., Müller, U., Grimm, H.S., Riemenschneider, M., and Hartmann, T. (2011) Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease. J. Neurochem. 226, 916-925
28. Winkler, E., Kamp, F., Scheuring, J., Ebke, A., Fukumori, A., and Steiner, H. (2012) Generation of Alzheimer disease-associated amyloid b42/43 peptide by g-secretase can be inhibited directly by modulation of membrane thickness. J. Biol. Chem. 287, 21326-21334
29. Osenkowski, P., Ye, W., Wang, R., Wolfe, M.S., and Selkoe, D.J. (2008) Direct and potent regulation of gamma-secretase by its lipid microenvironment. J. Biol. Chem. 283, 22529-22540
30. Osawa, S., Funamoto, S., Nobuhara, M., Wada-Kakuda, S., Shimojo, M., Yagishita, S., and Ihara, Y. (2008) Phosphoinositides suppress gamma-secretase in both the detergent-soluble and-insoluble states. J. Biol. Chem. 283, 19283-19292
31. Janssen, M.J., Koorengevel, M.C., de Kruijff, B., and de Kroon, A.I. (2000) The phosphatidylcholine to phosphatidylethanolamine ratio of Saccharomyces cerevisiae varies with the growth phase. Yeast 16, 641-650
32. van Meer, G., Voelker, D.R., and Feigenson, G.W. (2008) Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112-124
33. Area-Gomez, E., Del Carmen Lara Castillo, M., Tambini, M.D., Guardia-Laguarta, C., de Groof, A.J., Madra, M., Ikenouchi, J., Umeda, M., Bird, T.D., Sturley, S.L., and Schon, E.A. (2012) Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J. 31, 4106-4123
34. Schon, E.A. and Area-Gomez, E. (2013) Mitochondriaassociated ER membranes in Alzheimer disease. Mol. Cell. Neurosci. 55, 26-36
35. Vance, J.E. and Tasseva, G. (2013) Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochem. Biophys. Acta 1831, 543-554
36. Wells, K., Farooqui, A.A., Liss, L., and Horrocks, L.A. (1995) Neural membrane phospholipids in Alzheimer disease. Neurochem. Res. 20, 1329-1333
37. Guan, Z., Wang, Y., Cairns, N.J., Lantos, P.L., Dallner, G., and Sindelar, P.J. (1999) Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J. Neuropathol. Exp. Neurol. 58, 740-747
38. Farooqui, A.A. (2010) Studies on plasmalogen-selective phospholipase A2 in brain. Mol. Neurobiol. 41, 267-273
39. Ginsberg, L., Xuereb, J.H., and Gershfeld, N.L. (1998) Membrane instability, plasmalogen content, and Alzheimer's disease. J. Neurochem. 70, 2533-2538
40. Rothhaar, T.L., Grösgen, S., Haupenthal, V.J., Burg, V.K., Hundsdörfer, B., Mett, J., Riemenschneider, M., Grimm, H.S., Hartmann, T., and Grimm, M.O. (2012) Plasmalogens inhibit APP processing by directly affecting g-secretase activity in Alzheimer's disease. Scientific World J 2012, 141240
41. Goodenowe, D.B., Cook, L.L., Liu, J., Lu, Y., Jayasinghe, D.A., Ahiahonu, P.W.K., Doug Heath, D., Yamazaki, Y., Flax, J., Krenitsky, K.F., Sparks, D.L., Lerner, A., Friedland, R.P., Kudo, T., Kamino, K., Morihara, T., Takeda, M., and Wood, P.L. (2007) Peripheral ethanolamine plasmalogen deficiency: A logical causative factor in Alzheimer's disease and dementia. J. Lipid Res. 48, 2485-2498
42. Nishimukai, M., Wakisaka, T., and Hara, H. (2003) Ingestion of plasmalogen markedly increased plasmalogen levels of blood plasma in rats. Lipids 38, 1227-1235
43. Mawatari, S., Katafuchi, T., Miake, K., and Fujino, T. (2012) Dietary plasmalogen increases erythrocyte membrane plasmalogen in rats. Lipids Health Dis. 11, 161